Your browser doesn't support javascript.
SARS-CoV-2 in Zimbabwe: milestones and challenges faced towards achieving the expected 60% herd immunity.
Kouamou, Vinie; Matarise, Richard; Santos, Elizabeth Dos; Elose, Nyasha; Manasa, Justen.
  • Kouamou V; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
  • Matarise R; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
  • Santos ED; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
  • Elose N; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
  • Manasa J; Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
Pan Afr Med J ; 39: 255, 2021.
Article in English | MEDLINE | ID: covidwho-1468748
ABSTRACT
In response to COVID-19 pandemic, the Zimbabwe government put in place various rigorous measures to curb the spread of the virus. Although roll-out and access to COVID-19 vaccines in Africa have been slow, the World Health Organization (WHO)-led COVID-19 Vaccines Global Access (COVAX) consortium and the African vaccine acquisition task team are striving to provide 720 million doses of COVID-19 vaccines to achieve 60% coverage in Africa by June, 2022. In line with this, the Zimbabwe vaccination programme commenced on the 26th February 2021 and as of 9th June 2021, approximately, 2.6% of the population have been fully vaccinated in the country. Although the COVID-19 pandemic has crippled the economy and caused significant strain on the public health system, much has been done in the country since the first case was recorded (20th March 2020). However, much more needs to be done to finally reach the expected 60% herd immunity by June 2022.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunity, Herd / Pandemics / COVID-19 Vaccines / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: Pan Afr Med J Year: 2021 Document Type: Article Affiliation country: Pamj.2021.39.255.30331

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunity, Herd / Pandemics / COVID-19 Vaccines / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: Pan Afr Med J Year: 2021 Document Type: Article Affiliation country: Pamj.2021.39.255.30331